Status: Recruiting
A Study of the Safety of Vonoprazan Exposure in Pregnant Women and Their Offspring
The main objective of the study is to compare the maternal, fetal, and infant outcomes of pregnant women who are exposed to vonoprazan during pregnancy with outcomes of an internal comparison cohort of pregnant women who are unexposed to vonoprazan during pregnancy but who may be exposed to other products for the treatment of conditions for which vonoprazan may be prescribed.
Participants needed: 728
Trial details
Age: 15-50Biological sex: FemaleType: ObservationalSponsor: Phathom Pharmaceuticals, Inc.Updated: May 22, 2025Locations: 1Duration: 12 Months
Eligibility criteria
Women 15 to 50 years of age. [+5]
Occurrence of pregnancy outcome prior to first contact with the virtual research... [+2]